Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock

American Journal of Respiratory and Critical Care Medicine

Volumn 178, Issue 3, 2008, Pages 276-282

  Wong, Hector R ^a,d   Cvijanovich, Natalie ^b   Wheeler, Derek S ^a   Bigham, Michael T ^a   Monaco, Marie ^a   Odoms, Kelli ^a   Macias, William L ^c   Williams, Mark D ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Interleukin 8; Pediatrics; Septic shock; Stratification

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 8;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CHILD; CONFIDENCE INTERVAL; DATA BASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FISHER EXACT TEST; FOLLOW UP; GENE EXPRESSION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MORTALITY; PATHOGENESIS; POST HOC ANALYSIS; PREDICTION AND FORECASTING; PRIORITY JOURNAL; RNA ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; STRATIFICATION; STUDENT T TEST; SURVIVAL RATE;

BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; INTERLEUKIN-8; MALE; PREDICTIVE VALUE OF TESTS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SURVIVAL ANALYSIS;

EID: 48249148704     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200801-131OC     Document Type: Article

References (37)

1. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003;167:695-701.
2. Shanley TP, Hallstrom C,Wong HR. Sepsis. In: Fuhrman BP, Zimmerman JJ, editors. Pediatric critical care medicine, 3rd ed. St. Louis: Mosby; 2006. pp. 1474-1493.
3. Nadel S, Goldstein B, Williams MD, Dalton H, Peters M, Macias WL, Abd-Allah SA, Levy H, Angle R, Wang D, et al. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet 2007;369:836-843.
4. Marshall JC, Vincent JL, Guyatt G, Angus DC, Abraham E, Bernard G, Bombardier C, Calandra T, Jorgensen HS, Sylvester R, et al. Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med 2005;33:1708-1716.
5. Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med 2005;6(3, Suppl):S3-S5.
6. Wong HR, Shanley TP, Sakthivel B, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Doctor A, Kalyanaraman M, Tofil NM, et al. Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics 2007;30:146-155.
7. Shanley TP, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Doctor A, Kalyanaraman M, Tofil NM, Penfil S, Monaco M, et al. Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007;13:495-508.
8. Wong HR. Pediatric septic shock treatment: new clues from genomic profiling. Pharmacogenomics 2007;8:1287-1290.
9. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6:2-8.
10. Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR Jr. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 1997;43:1749-1756.
11. Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 2001; 45:27-36.
12. Kellar KL, Iannone MA. Multiplexed microsphere-based flow cytometric assays. Exp Hematol 2002;30:1227-1237.
13. Chen R, Lowe L, Wilson JD, Crowther E, Tzeggai K, Bishop JE, Varro R. Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology. Clin Chem 1999;45:1693-1694.
14. Cook EB, Stahl JL, Lowe L, Chen R, Morgan E, Wilson J, Varro R, Chan A, Graziano FM, Barney NP. Simultaneous measurement of six cytokines in a single sample of human tears using micro particle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods 2001;254:109-118.
15. Oliver KG, Kettman JR, Fulton RJ. Multiplexed analysis of human cytokines by use of the FlowMetrix system. Clin Chem 1998;44:2057-2060.
16. Remick DG. Interleukin-8. Crit Care Med 2005;33(12, Suppl):S466-S467.
17. Harris MC, D'Angio CT, Gallagher PR, Kaufman D, Evans J, Kilpatrick L. Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. J Pediatr 2005;147: 462-468.
18. Verboon-Maciolek MA, Thijsen SF, Hemels MA, Menses M, van Loon AM, Krediet TG, Gerards LJ, Fleer A, Voorbij HA, Rijkers GT. Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res 2006;59:457-461.
19. Ng PC, Lam HS. Diagnostic markers for neonatal sepsis. Curr Opin Pediatr 2006;18:125-131.
20. Horisberger T, Harbarth S, Nadal D, Baenziger O, Fischer JE. G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial. Crit Care 2004;8:R443-R450.
21. Santana Reyes C, Garcia-Munoz F, Reyes D, Gonzalez G, Dominguez C, Domenech E. Role of cytokines (interleukin-1beta, 6, 8, tumour necrosis factor-alpha, and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis. Acta Paediatr 2003;92:221-227.
22. Damas P, Canivet JL, de Groote D, Vrindts Y, Albert A, Franchimont P, Lamy M. Sepsis and serum cytokine concentrations. Crit Care Med 1997;25:405-412.
23. Vermont CL, Hazelzet JA, de Kleijn ED, van den Dobbelsteen GP, de Groot R. CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity. Crit Care 2006;10:R33.
24. Lin KJ, Lin J, Hanasawa K, Tani T, Kodama M. Interleukin-8 as a predictor of the severity of bacteremia and infectious disease. Shock 2000;14:95-100.
25. Kern WV, Heiss M, Steinbach G. Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy. Clin Infect Dis 2001;32:832-835.
26. Van der Kaay DC, De Kleijn ED, De Rijke YB, Hop WC, De Groot R, Hazelzet JA. Procalcitonin as a prognostic marker in meningococcal disease. Intensive Care Med 2002;28:1606-1612.
27. Schots R, Kaufman L, Van Riet I, Ben Othman T, De Waele M, Van Camp B, Demanet C. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 2003; 17:1150-1156.
28. Ozbalkan Z, Aslar AK, Yildiz Y, Aksaray S. Investigation of the course of proinflammatory and anti-inflammatory cytokines after burn sepsis. Int J Clin Pract 2004;58:125-129.
29. Livaditi O, Kotanidou A, Psarra A, Dimopoulou I, Sotiropoulou C, Augustatou K, Papasteriades C, Armaganidis A, Roussos C, Orfanos SE, et al. Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis. Cytokine 2006;36:283-290.
30. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007;11:R49.
31. Rivers EP, Kruse JA, Jacobsen G, Shah K, Loomba M, Otero R, Childs EW. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007;35: 2016-2024.
32. Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992;60:2835-2842.
33. Fujishima S, Sasaki J, Shinozawa Y, Takuma K, Kimura H, Suzuki M, Kanazawa M, Hori S, Aikawa N. Serum MIP-1 alpha and IL-8 in septic patients. Intensive Care Med 1996;22:1169-1175.
34. Hein OV, Misterek K, Tessmann JP, van Dossow V, Krimphove M, Spies C. Time course of endothelial damage in septic shock: prediction of outcome. Crit Care 2005;9:R323-R330.
35. Marshall JC. Biomarkers of sepsis. Curr Infect Dis Rep 2006;8:351-357.
36. Marshall JC. The staging of sepsis: understanding heterogeneity in treatment efficacy. Crit Care 2005;9:626-628.
37. Dellinger RP, Abraham E, Bernard G, Marshall JC, Vincent JL. Controversies in sepsis clinical trials: proceedings of a meeting of the International Sepsis Forum, Lausanne, Switzerland, September 29, 2001. J Crit Care 2006;21:38-47.